K Wilkinson, N DeMarse, N Kingery, J El Khoury (2012). Characterization of the affinity of CD36 toamyloid-β and to the CD36 inhibitor ursolic acid. Manuscript in preparation.
KWilkinson and J El Khoury (2012). Microglial Scavenger Receptors and their Roles inthe Pathogenesis of Alzheimer’s Disease. International Journal of Alzheimer’sDisease, Microglia in Alzheimer's Disease Special Issue, Volume 2012.
KWilkinson, N Kingery, J El Khoury (2012). Decreased AD-like pathology in PS1APP-CD36-/-mouse brains due to upregulation of neprilysin expression and control ofamyloid-β plaque formation. Manuscriptin preparation.
D Frenkel*, KWilkinson* (Equal contributions),SE Hickman, L Zhao, TK Means, L Puckett, D Farfara, HL Weiner, J El Khoury (2012). Scara1 deficiencyimpairs clearance of amyloid-β by mononuclear phagocytes and acceleratesprogression of Alzheimer’s-like disease. Under review at Nature Communications.
K Wilkinson, JD Boyd, M Glicksman, KJ Moore, J EL Khoury(2011). A high content screen identifiesinhibitors of amyloid-β and its receptor CD36. Journal of Biological Chemistry. 286, 34914–34922.
CR Stewart*,LM Stuart*, K Wilkinson* (Equal contributions), J van Gils, J Deng, A Halle, KJRayner, L Boyer, R Zhong, WA Frazier, J EL Khoury, DT Golenbock, KJ Moore(2010). CD36 ligands promote sterileinflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunology, 11, 155 – 161.
· Article featured in Research Highlights of Nature Reviews Immunology, 10, 82 (2010).